Targeting of blocking programmed cell death protein (PD-1) and cytotoxic t-lymphocytes antigen 4 (CTLA-4) have prolonged malignant melanoma relapse-free, distant metastasis-free, and overall survival times [68]. The gene discussed is CTLA4; the disease is melanoma.